![1-(3-benzyl-2-imino-2,3-dihydro-1H-benzo[d]imidazol-1-yl)-3,3-dimethylbutan-2-one hydrobromide structure](/static/products/429/429645-05-6.png)
1-(3-benzyl-2-imino-2,3-dihydro-1H-benzo[d]imidazol-1-yl)-3,3-dimethylbutan-2-one hydrobromide
TL;DR: 1-(3-benzyl-2-imino-2,3-dihydro-1H-benzo[d]imidazol-1-yl)-3,3-dimethylbutan-2-one hydrobromide (CAS 429645-05-6) is a chemical compound with molecular formula C20H24BrN3O and molecular weight 401.11 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
1-(3-benzyl-2-iminobenzimidazol-1-yl)-3,3-dimethylbutan-2-one;hydrobromide
Also Known As: 1-(3-benzyl-2-imino-2,3-dihydro-1H-benzo[d]imidazol-1-yl)-3,3-dimethylbutan-2-one hydrobromide, 1-(3-benzyl-2-iminobenzimidazol-1-yl)-3,3-dimethylbutan-2-one hydrobromide
| Molecular Formula | C20H24BrN3O |
|---|---|
| Molecular Weight | 401.11 g/mol |
| LogP | 4.16367 |
| Topological Polar Surface Area | 50.78 Ų |
| Hydrogen Bond Donors | 1 |
| Hydrogen Bond Acceptors | 2 |
| Rotatable Bonds | 4 |
| Exact Mass | 401.11026 |
| Heavy Atoms | 25 |
| Complexity | 932.9699 |
Chemical Identifiers
| CAS Number | 429645-05-6 |
|---|---|
| SMILES | CC(C)(C)C(=O)CN1C2=CC=CC=C2N(C1=N)CC3=CC=CC=C3.Br |
Product Overview
1-(3-benzyl-2-imino-2,3-dihydro-1H-benzo[d]imidazol-1-yl)-3,3-dimethylbutan-2-one hydrobromide (CAS 429645-05-6), with molecular formula C20H24BrN3O and molecular weight 401.11 g/mol. IUPAC: 1-(3-benzyl-2-iminobenzimidazol-1-yl)-3,3-dimethylbutan-2-one;hydrobromide.
Chemical Property Profile of 1-(3-benzyl-2-imino-2,3-dihydro-1H-benzo[d]imidazol-1-yl)-3,3-dimethylbutan-2-one hydrobromide
Property Insights of 1-(3-benzyl-2-imino-2,3-dihydro-1H-benzo[d]imidazol-1-yl)-3,3-dimethylbutan-2-one hydrobromide
The XLogP value of 4.16367 indicates that 1-(3-benzyl-2-imino-2,3-dihydro-1H-benzo[d]imidazol-1-yl)-3,3-dimethylbutan-2-one hydrobromide is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. With a topological polar surface area (TPSA) of 50.78 Ų, 1-(3-benzyl-2-imino-2,3-dihydro-1H-benzo[d]imidazol-1-yl)-3,3-dimethylbutan-2-one hydrobromide exhibits relatively low polarity, potentially indicating favorable cell membrane permeability. Following Lipinski's Rule of Five, 1-(3-benzyl-2-imino-2,3-dihydro-1H-benzo[d]imidazol-1-yl)-3,3-dimethylbutan-2-one hydrobromide has 1 hydrogen bond donor(s) and 2 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of 1-(3-benzyl-2-imino-2,3-dihydro-1H-benzo[d]imidazol-1-yl)-3,3-dimethylbutan-2-one hydrobromide?
The CAS number of 1-(3-benzyl-2-imino-2,3-dihydro-1H-benzo[d]imidazol-1-yl)-3,3-dimethylbutan-2-one hydrobromide is 429645-05-6.
What is the molecular formula of 1-(3-benzyl-2-imino-2,3-dihydro-1H-benzo[d]imidazol-1-yl)-3,3-dimethylbutan-2-one hydrobromide?
The molecular formula of 1-(3-benzyl-2-imino-2,3-dihydro-1H-benzo[d]imidazol-1-yl)-3,3-dimethylbutan-2-one hydrobromide is C20H24BrN3O.
What is the molecular weight of 1-(3-benzyl-2-imino-2,3-dihydro-1H-benzo[d]imidazol-1-yl)-3,3-dimethylbutan-2-one hydrobromide?
The molecular weight of 1-(3-benzyl-2-imino-2,3-dihydro-1H-benzo[d]imidazol-1-yl)-3,3-dimethylbutan-2-one hydrobromide is 401.11 g/mol.
Where can I buy 1-(3-benzyl-2-imino-2,3-dihydro-1H-benzo[d]imidazol-1-yl)-3,3-dimethylbutan-2-one hydrobromide?
You can request a quote for 1-(3-benzyl-2-imino-2,3-dihydro-1H-benzo[d]imidazol-1-yl)-3,3-dimethylbutan-2-one hydrobromide directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for 1-(3-benzyl-2-imino-2,3-dihydro-1H-benzo[d]imidazol-1-yl)-3,3-dimethylbutan-2-one hydrobromide?
Yes, KEHONG BIO provides custom synthesis services for 1-(3-benzyl-2-imino-2,3-dihydro-1H-benzo[d]imidazol-1-yl)-3,3-dimethylbutan-2-one hydrobromide and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.